What To Expect From Theravance Biopharma Inc (TBPH) Q3 2024 Earnings [Yahoo! Finance]
Theravance Biopharma, Inc. - Ordinary Shares (TBPH)
Last theravance biopharma, inc. - ordinary shares earnings: 2/24 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.theravance.com/investor-relations
Company Research
Source: Yahoo! Finance
The consensus estimate for Q3 2024 revenue is $15.34 million, and the earnings are expected to come in at -$0.23 per share. The full year 2024's revenue is expected to be $60.2 million and the earnings are expected to be -$1.01 per share. More detailed estimate data can be found on the Forecast page Warning! GuruFocus has detected 3 Warning Signs with TBPH. Over the past 90 days, revenue estimates for Theravance Biopharma Inc ( NASDAQ:TBPH ) have remained steady at $60.2 million for the full year 2024 and $87 million for 2025. Similarly, earnings estimates have remained unchanged at -$1.01 per share for the full year 2024 and $0.06 per share for 2025. In the previous quarter of 2024-06-30, Theravance Biopharma Inc's ( NASDAQ:TBPH ) actual revenue was $14.26 million, which missed analysts' revenue expectations of $15.453 million by -7.75%. Theravance Biopharma Inc's ( NASDAQ:TBPH ) actual earnings were -$0.34 per share, which missed analysts' earnings expectations of -$0.208 per
Show less
Read more
Impact Snapshot
Event Time:
TBPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TBPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TBPH alerts
High impacting Theravance Biopharma, Inc. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
TBPH
News
- KBR Stock Soars 5%: Activist Investor Pushes for Breakup to Unlock 50% Value Surge [Yahoo! Finance]Yahoo! Finance
- Theravance Biopharma to Conduct Investor Meetings During the J.P. Morgan 43rd Annual Healthcare ConferencePR Newswire
- The past five years for Theravance Biopharma (NASDAQ:TBPH) investors has not been profitable [Yahoo! Finance]Yahoo! Finance
- Theravance Biopharma to Participate in an Upcoming Investor ConferencePR Newswire
- Kevin Krause named President and CEO of ArrePath [Yahoo! Finance]Yahoo! Finance
TBPH
Earnings
- 11/12/24 - Miss
TBPH
Sec Filings
- 11/22/24 - Form 4
- 11/22/24 - Form 4
- 11/22/24 - Form 4
- TBPH's page on the SEC website